Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1988 2
1989 2
1991 2
1992 9
1993 3
1994 3
1995 2
1997 4
1998 9
1999 7
2000 4
2001 9
2002 6
2003 8
2004 9
2005 6
2006 9
2007 1
2008 4
2009 6
2010 4
2011 5
2012 3
2013 6
2014 7
2015 10
2016 6
2017 8
2018 4
2019 6
2020 3
2021 3
2022 7
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 11699402

163 results

Results by year

Filters applied: . Clear all
Page 1
Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
Sanz MA, López J, Lahuerta JJ, Rovira M, Batlle M, Pérez C, Vázquez L, Julià A, Palau J, Gutiérrez M, Capote FJ, Ramos F, Benlloch L, Larrea L, Jarque I; Spanish PETHEMA Group. Sanz MA, et al. J Antimicrob Chemother. 2002 Jul;50(1):79-88. doi: 10.1093/jac/dkf087. J Antimicrob Chemother. 2002. PMID: 12096010 Clinical Trial.
A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies.
Bow EJ, Rotstein C, Noskin GA, Laverdiere M, Schwarer AP, Segal BH, Seymour JF, Szer J, Sanche S. Bow EJ, et al. Clin Infect Dis. 2006 Aug 15;43(4):447-59. doi: 10.1086/505393. Epub 2006 Jul 10. Clin Infect Dis. 2006. PMID: 16838234 Clinical Trial.
Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison.
Gorschlüter M, Hahn C, Fixson A, Mey U, Ziske C, Molitor E, Horré R, Sauerbruch T, Marklein G, Schmidt-Wolf IG, Glasmacher A. Gorschlüter M, et al. Support Care Cancer. 2003 Jun;11(6):362-70. doi: 10.1007/s00520-003-0463-7. Epub 2003 Apr 11. Support Care Cancer. 2003. PMID: 12690546 Clinical Trial.
Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients.
Viscoli C, Cometta A, Kern WV, Bock R, Paesmans M, Crokaert F, Glauser MP, Calandra T; International Antimicrobial Therapy Group of the European Organization for Research and Treatment of Cancer. Viscoli C, et al. Clin Microbiol Infect. 2006 Mar;12(3):212-6. doi: 10.1111/j.1469-0691.2005.01297.x. Clin Microbiol Infect. 2006. PMID: 16451406 Free article. Clinical Trial.
163 results